SF-6D versus EQ-5D: reasons for differences in utility scores and impact on reported cost-utility

被引：61
|
作者：
Grieve, Richard [1 ]
Grishchenko, Marina [1 ]
Cairns, John [1 ]
机构：
[1] London Sch Hyg & Trop Med, Hlth Serv Res Unit, London WC1E 7HT, England
来源：
EUROPEAN JOURNAL OF HEALTH ECONOMICS | 2009年 / 10卷 / 01期
关键词：
Cost-utility; EQ-5D; SF-6D; Health utilities; CHRONIC HEPATITIS-C; PLUS RIBAVIRIN; HEALTH; PEGINTERFERON; EUROQOL; THERAPY;
D O I：
10.1007/s10198-008-0097-2
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
The choice of instrument (e.g. EQ-5D vs. SF-6D) can lead to different health-related utility scores, but it is unclear why these differences arise and whether they change cost utility analysis (CUA) results. This paper addresses these issues using a case study where using SF-6D rather EQ-5D led to greater utility gain and a lower cost per QALY for treatment. The paper examines reasons for this difference. This paper finds that an important factor was the inclusion in the SF-6D descriptive system of separate items for "vitality" and "social functioning", not explicitly included in EQ-5D. Further studies are required that examine the impact of the choice of instrument on cost-utility.
引用
收藏
页码：15 / 23
页数：9
相关论文
共 50 条
  • [41] Systematic Review and Empirical Comparison of Contemporaneous EQ-5D and SF-6D Group Mean Scores
    Whitehurst, David G. T.
    Bryan, Stirling
    Lewis, Martyn
    MEDICAL DECISION MAKING, 2011, 31 (06) : E34 - E44
  • [42] Assessing the Impact of EQ-5D Country-specific Value Sets on Cost-utility Outcomes
    van Dongen, Johanna M.
    Ben, Angela Jornada
    Finch, Aureliano P.
    Rossenaar, Milou M. M.
    Biesheuvel-Leliefeld, Karolien E. M.
    Apeldoorn, Adrie T.
    Ostelo, Raymond W. J. G.
    van Tulder, Maurits W.
    van Marwijk, Harm W. J.
    Bosmans, Judith E.
    MEDICAL CARE, 2021, 59 (01) : 82 - 90
  • [43] Comparison of the EQ-5D and the SF-6D Utility Measures in 813 Patients with Early Arthritis: Results from the ESPOIR Cohort
    Gaujoux-Viala, Cecile
    Rat, Anne-Christine
    Guillemin, Francis
    Flipo, Rene-Marc
    Fardellone, Patrice
    Bourgeois, Pierre
    Fautrel, Bruno
    JOURNAL OF RHEUMATOLOGY, 2011, 38 (08) : 1576 - 1584
  • [44] Measuring the quality of life in cost-utility analyses: the Dutch EQ-5D tariff
    Lamers, LM
    Stalmeier, PFM
    McDonnell, J
    Krabbe, PFM
    van Busschbach, JJ
    NEDERLANDS TIJDSCHRIFT VOOR GENEESKUNDE, 2005, 149 (28) : 1574 - 1578
  • [45] Estimation of minimally important differences in EQ-5D utility and VAS scores in cancer
    A Simon Pickard
    Maureen P Neary
    David Cella
    Health and Quality of Life Outcomes, 5
  • [46] Estimation of minimally important differences in EQ-5D utility and VAS scores in cancer
    Pickard, A. Simon
    Neary, Maureen P.
    Cella, David
    HEALTH AND QUALITY OF LIFE OUTCOMES, 2007, 5 (1)
  • [47] Comparison of the EQ-5D-3L and the SF-6D (SF-12) contemporaneous utility scores in patients with cardiovascular disease
    Kularatna, Sanjeewa
    Byrnes, Joshua
    Chan, Yih Kai
    Ski, Chantal F.
    Carrington, Melinda
    Thompson, David
    Stewart, Simon
    Scuffham, Paul A.
    QUALITY OF LIFE RESEARCH, 2017, 26 (12) : 3399 - 3408
  • [48] Comparison of the EQ-5D-3L and the SF-6D (SF-12) contemporaneous utility scores in patients with cardiovascular disease
    Sanjeewa Kularatna
    Joshua Byrnes
    Yih Kai Chan
    Chantal F. Ski
    Melinda Carrington
    David Thompson
    Simon Stewart
    Paul A. Scuffham
    Quality of Life Research, 2017, 26 : 3399 - 3408
  • [49] A comparison of the EQ-5D and the SF-6D in patients with pulmonary arterial hypertension
    Brown, MC
    VALUE IN HEALTH, 2005, 8 (06) : A4 - A4
  • [50] Comparing the Performance of the SF-6D and the EQ-5D in Different Patient Groups
    Ferreira, Lara N.
    Ferreira, Pedro L.
    Pereira, Luis N.
    ACTA MEDICA PORTUGUESA, 2014, 27 (02): : 236 - 245
12345